Landos Biopharma (LABP)
(Delayed Data from NSDQ)
$22.80 USD
0.00 (0.01%)
Updated May 23, 2024 12:18 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/14/24 |
---|---|
Current Quarter | -0.88 |
EPS Last Quarter | -1.43 |
Last EPS Surprise | -43.00% |
ABR | 3.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.19 |
Next Year | -1.69 |
EPS (TTM) | -3.99 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.88 | -0.80 | -2.19 | -1.69 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.63 | -0.48 | -2.35 | -2.07 |
High Estimate | -0.63 | -0.48 | -2.03 | -1.30 |
Low Estimate | -1.12 | -1.12 | -2.35 | -2.07 |
Year ago EPS | -0.63 | -0.94 | -3.50 | -2.19 |
Year over Year Growth Est. | -39.68% | 14.89% | 37.43% | 23.06% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.88 | -0.80 | -2.19 | -1.69 |
7 Days Ago | -0.88 | -0.80 | -2.19 | -1.69 |
30 Days Ago | -0.88 | -0.80 | -2.19 | -1.69 |
60 Days Ago | -1.12 | -1.12 | -2.03 | -1.30 |
90 Days Ago | -1.12 | -1.12 | -2.03 | -1.30 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.88 | -0.80 | -2.19 | -1.69 |
Zacks Consensus Estimate | -0.88 | -0.80 | -2.19 | -1.69 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.43 | -0.99 | -0.94 | -0.63 | NA |
Estimate | -1.00 | -0.91 | -0.79 | -1.10 | NA |
Difference | -0.43 | -0.08 | -0.15 | 0.47 | -0.05 |
Surprise | -43.00% | -8.79% | -18.99% | 42.73% | -7.01% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more